Franklin Resources Inc Nevro Corp Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.96 - $13.59 $19,724 - $33,676	2,478 Added 14.16%	19,984 $168,000
Q1 2024 May 13, 2024	SELL	$13.56 - $20.78 $298 - $457	-22 Reduced 0.13%	17,506 $252,000
Q4 2023 Feb 09, 2024	SELL	$14.18 - $22.31 $368 - $580	-26 Reduced 0.15%	17,528 $377,000
Q3 2023 Nov 13, 2023	SELL	$18.22 - $25.85 $6.98 Million - $9.9 Million	-382,835 Reduced 95.62%	17,554 $337,000
Q2 2023 Aug 11, 2023	BUY	$22.62 - $39.32 $354,930 - $616,970	15,691 Added 4.08%	400,389 $10.2 Million
Q1 2023 May 12, 2023	SELL	$30.17 - $41.11 $20,002 - $27,255	-663 Reduced 0.17%	384,698 $13.9 Million
Q4 2022 Feb 10, 2023	BUY	$36.43 - $49.4 $2.39 Million - $3.24 Million	65,539 Added 20.49%	385,361 $15.3 Million
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $26.7 Million - $34.8 Million	-656,596 Reduced 67.25%	319,822 $14.9 Million
Q2 2022 Aug 11, 2022	SELL	$40.85 - $77.67 $275,410 - $523,651	-6,742 Reduced 0.69%	976,418 $42.8 Million
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $4.3 Million - $6.61 Million	71,803 Added 7.88%	983,160 $71.1 Million
Q4 2021 Feb 11, 2022	SELL	$81.07 - $121.29 $207,458 - $310,381	-2,559 Reduced 0.28%	911,357 $73.9 Million
Q3 2021 Nov 12, 2021	SELL	$101.99 - $166.36 $6.05 Million - $9.87 Million	-59,324 Reduced 6.1%	913,916 $106 Million
Q2 2021 Aug 13, 2021	SELL	$141.6 - $179.06 $6.39 Million - $8.08 Million	-45,104 Reduced 4.43%	973,240 $161 Million
Q1 2021 May 13, 2021	SELL	$132.81 - $182.18 $2.47 Million - $3.38 Million	-18,564 Reduced 1.79%	1,018,344 $142 Million
Q4 2020 Feb 10, 2021	SELL	$138.17 - $184.34 $2.12 Million - $2.83 Million	-15,358 Reduced 1.46%	1,036,908 $179 Million
Q3 2020 Nov 12, 2020	SELL	$114.09 - $145.51 $4.03 Million - $5.14 Million	-35,338 Reduced 3.25%	1,052,266 $147 Million
Q2 2020 Aug 13, 2020	SELL	$89.45 - $129.85 $13.3 Million - $19.3 Million	-148,453 Reduced 12.01%	1,087,604 $146 Million
Q1 2020 May 13, 2020	SELL	$70.23 - $144.31 $6.78 Million - $13.9 Million	-96,587 Reduced 7.25%	1,236,057 $124 Million
Q4 2019 Feb 12, 2020	SELL	$76.41 - $117.54 $13.3 Million - $20.5 Million	-174,128 Reduced 11.56%	1,332,644 $157 Million
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $35.3 Million - $52.2 Million	-573,347 Reduced 27.56%	1,506,772 $130 Million
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $2.51 Million - $2.89 Million	-43,172 Reduced 2.03%	2,080,119 $135 Million
Q1 2019 May 14, 2019	BUY	$35.52 - $62.62 $3.07 Million - $5.41 Million	86,375 Added 4.24%	2,123,291 $133 Million
Q4 2018 Feb 12, 2019	SELL	$35.43 - $56.29 $9.73 Million - $15.5 Million	-274,589 Reduced 11.88%	2,036,916 $79.2 Million
Q3 2018 Nov 13, 2018	BUY	$44.22 - $75.47 $24.9 Million - $42.5 Million	562,933 Added 32.19%	2,311,505 $132 Million
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $13.2 Million - $16.8 Million	181,797 Added 11.6%	1,748,572 $140 Million
Q1 2018 May 10, 2018	SELL	$69.46 - $88.57 $1.78 Million - $2.27 Million	-25,676 Reduced 1.61%	1,566,775 $136 Million
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $2.59 Million - $3.66 Million	39,224 Added 2.53%	1,592,451 $110 Million
Q3 2017 Nov 13, 2017	BUY	$80.87 - $91.08 $126 Million - $141 Million	1,553,227	1,553,227 $141 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$17.4 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$14.8 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$14.3 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$9.7 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$8.32 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $140M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account